Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary impairment after tuberculosis.

Jotam G Pasipanodya1, Thaddeus L Miller, Mauricio Vecino

  • 1Department of Medicine, University of North Texas Health Science Center at Fort Worth, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.

Chest
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Innovative Model for Graduate Medical Education Faculty Development Through Physician-in-Training Delivery.

HCA healthcare journal of medicine·2026
Same author

Leveraging Innovative Electronic Health Record Data to Characterize Social Determinants of Health Among Survivors of Cancer in Persistent Poverty Areas: Cross-Sectional Study.

JMIR cancer·2026
Same author

Cytokine-mediated, organ-specific immune modulation and dysregulation of innate lymphocytes in sepsis.

Seminars in immunopathology·2026
Same author

Blood Pressure Trajectories in Young Adulthood and Midlife Steatotic Liver Disease.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2.

Blood and lymphatic cancer : targets and therapy·2026
Same author

Presentations of Cutaneous Disease in Various Skin Pigmentations: Tinea Corporis.

HCA healthcare journal of medicine·2026

Pulmonary impairment is common after tuberculosis treatment, affecting nearly 60% of survivors. This lung damage can lead to long-term disability, underscoring the need for better prevention and post-treatment care for tuberculosis patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Public Health

Background:

  • Pulmonary impairment following tuberculosis (TB) treatment is not widely studied across diverse populations.
  • Understanding long-term respiratory health after TB cure is crucial for patient outcomes.

Purpose of the Study:

  • To compare pulmonary function in patients who completed tuberculosis treatment versus those with latent tuberculosis infection (LTBI).
  • To identify the prevalence and risk factors for pulmonary impairment after tuberculosis therapy.

Main Methods:

  • A case-control study involving 107 patients with treated pulmonary tuberculosis and 210 patients with LTBI.
  • Pulmonary function tests (PFTs) were used to assess lung capacity and airflow.

Main Results:

Related Experiment Videos

  • Nearly 60% of treated TB patients exhibited pulmonary impairment compared to 20% of LTBI controls.
  • Treated TB patients showed significantly lower FVC, FEV1, and FEV1/FVC ratios.
  • Survivors of TB were 5.4 times more likely to have abnormal PFTs, with US birth and older age increasing impairment risk.

Conclusions:

  • Pulmonary impairment after tuberculosis is a significant cause of disability globally.
  • Findings support enhanced TB prevention and post-treatment monitoring strategies.
  • Microbiological cure of TB marks only the beginning of managing long-term health consequences.